Clinical Trial

Uncertainty About the Benefits of New Cancer Drugs and Patients' Treatment Preferences

Name: Uncertainty About the Benefits of New Cancer Drugs and Patients' Treatment Preferences — clinical trial record (NCT07694310)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

This study of current or former cancer patients will evaluate the effect of learning about uncertainties with the benefits of a new cancer drug on their hypothetical decisions to take the drug and their perceptions of the drug's effectiveness.

Trial Details

NCT Number	NCT07694310
Lead Sponsor	London School of Economics and Political Science Collaborators: Harvard Medical School and Harvard Pilgrim Health Care Institute
Conditions	Cancer
Enrollment	3,000 participants
Start Date	2026-07-14
Primary Completion	2026-10-01 (estimated)
Study Completion	2026-10-01 (estimated)
Updated on ClinicalTrials.gov	2026-08-04